Conclusion
Bioresorbable vascular scaffolds may represent the fourth revolution in PCI. In particular coronary subsets BVS may represent a paradigm shift. So far, published data on BVS use in bifurcations is scarce. Our personal experience with a provisional approach as first choice shows favourable procedural and acute clinical success creating a window of opportunities to expand the use of BVS towards more challenging coronary substrates. Prospective registries and ideally randomised trials should assess whether the theoretical benefits of BVS in bifurcation lesions can produce sustainable good clinical outcomes.